Solutions 30 SE | Mid-cap | Technology

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 709.8M
Total Liabilities 601.5M
Shareholders Equity 108.1M
Debt to Equity 5.56

Cash Flow Metrics

Revenue & Profitability Trend

Solutions 30 SE Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i996.0M1.1B904.6M874.0M814.8M
Cost of Goods Sold i376.3M400.7M375.1M338.0M288.0M
Gross Profit i619.7M656.3M529.5M536.0M526.8M
Gross Margin % i62.2%62.1%58.5%61.3%64.7%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i562.1M612.6M504.6M471.8M447.5M
Total Operating Expenses i562.1M612.6M504.6M471.8M447.5M
Operating Income i14.2M7.0M-14.6M26.1M47.9M
Operating Margin % i1.4%0.7%-1.6%3.0%5.9%
Non-Operating Items
Interest Income i1.6M400.0K400.0K6.9M423.0K
Interest Expense i10.5M7.2M2.7M2.8M2.6M
Other Non-Operating Income-----
Pre-tax Income i-13.8M-15.7M-43.3M17.1M44.1M
Income Tax i1.4M1.8M5.6M-5.4M8.4M
Effective Tax Rate % i0.0%0.0%0.0%-31.8%19.1%
Net Income i-15.1M-17.5M-49.1M22.5M35.8M
Net Margin % i-1.5%-1.7%-5.4%2.6%4.4%
Key Metrics
EBITDA i77.8M61.9M29.0M89.7M96.3M
EPS (Basic) i€-0.15€-0.21€-0.47€0.20€0.32
EPS (Diluted) i€-0.15€-0.21€-0.47€0.20€0.32
Basic Shares Outstanding i107127984107127984107127984107127984107127984
Diluted Shares Outstanding i107127984107127984107127984107127984107127984

Income Statement Trend

Solutions 30 SE Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i96.3M118.2M124.4M129.8M159.3M
Short-term Investments i-----
Accounts Receivable i74.3M82.3M72.0M185.1M66.8M
Inventory i24.7M25.7M25.4M20.3M22.0M
Other Current Assets-----
Total Current Assets i426.7M425.9M404.4M400.7M423.6M
Non-Current Assets
Property, Plant & Equipment i35.9M34.3M32.3M28.3M23.7M
Goodwill i214.1M223.8M230.5M244.6M257.9M
Intangible Assets i100.7M111.6M118.3M132.6M146.9M
Long-term Investments-----
Other Non-Current Assets--1.0K1.0K1.0K
Total Non-Current Assets i283.1M297.5M289.5M296.4M294.1M
Total Assets i709.8M723.4M693.9M697.1M717.7M
Liabilities
Current Liabilities
Accounts Payable i171.7M200.1M210.8M149.6M147.5M
Short-term Debt i49.1M63.4M58.1M52.4M50.4M
Current Portion of Long-term Debt-----
Other Current Liabilities21.0M15.1M13.4M10.7M5.4M
Total Current Liabilities i446.6M426.7M403.2M349.3M356.1M
Non-Current Liabilities
Long-term Debt i116.7M125.6M105.2M110.5M137.9M
Deferred Tax Liabilities i17.0M19.7M21.7M24.3M28.6M
Other Non-Current Liabilities100.0K-100.0K2.0K-1.0K
Total Non-Current Liabilities i154.9M172.4M145.1M156.2M191.7M
Total Liabilities i601.5M599.1M548.3M505.5M547.7M
Equity
Common Stock i13.7M13.7M13.7M13.7M13.7M
Retained Earnings i-15.8M-22.7M-50.1M21.5M34.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i108.1M124.7M145.3M191.6M170.0M
Key Metrics
Total Debt i165.8M189.0M163.3M162.9M188.2M
Working Capital i-19.9M-770.0K1.2M51.4M67.6M

Balance Sheet Composition

Solutions 30 SE Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-15.1M-17.5M-49.1M22.5M35.8M
Depreciation & Amortization i-----
Stock-Based Compensation i01.3M2.0M341.0K0
Working Capital Changes i42.5M-33.0M-30.1M-39.6M16.0M
Operating Cash Flow i37.9M-41.9M-74.5M-13.7M54.8M
Investing Activities
Capital Expenditures i-17.5M-20.9M-21.4M614.0K-5.2M
Acquisitions i-3.6M-20.8M-4.2M-5.1M-25.6M
Investment Purchases i-400.0K---455.0K-424.0K
Investment Sales i-200.0K400.0K--
Investing Cash Flow i-21.6M-41.5M-46.8M-24.2M-48.1M
Financing Activities
Share Repurchases i-0-700.0K0-
Dividends Paid i-----
Debt Issuance i7.9M53.6M8.6M4.3M30.1M
Debt Repayment i-22.2M-12.2M-14.3M-28.2M-24.1M
Financing Cash Flow i-14.3M41.3M-6.7M-23.9M5.5M
Free Cash Flow i40.0M12.5M36.6M47.5M136.8M
Net Change in Cash i2.0M-42.1M-128.0M-61.8M12.2M

Cash Flow Trend

Solutions 30 SE Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -11.13
Forward P/E 23.39
Price to Book 1.89
Price to Sales 0.18
PEG Ratio 23.39

Profitability Ratios

Profit Margin -1.59%
Operating Margin 2.13%
Return on Equity -12.97%
Return on Assets 1.23%

Financial Health

Current Ratio 0.96
Debt to Equity 157.26
Beta 1.49

Per Share Data

EPS (TTM) €-0.15
Book Value per Share €0.87
Revenue per Share €9.30

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
s30174.7M-11.131.89-12.97%-1.59%157.26
Capgemini SE 21.3B13.751.8914.32%7.07%55.23
Sopra Steria 3.2B11.311.5714.37%4.76%63.80
Neurones S.A 985.2M19.302.5812.05%6.10%0.10
Atos SE 965.5M0.09-31.04%17.29%-31.26
Aubay Société 639.6M16.112.1912.87%6.48%7.26

Financial data is updated regularly. All figures are in the company's reporting currency.